• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道渗透促进剂SNAC与癸酸钠(C)的效果比较:离体大鼠肠黏膜和肠囊

Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C): Isolated rat intestinal mucosae and sacs.

作者信息

Twarog Caroline, McCartney Fiona, Harrison Sabine M, Illel Brigitte, Fattal Elias, Brayden David J

机构信息

UCD School of Veterinary Medicine, Belfield, Dublin 4, Ireland; UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.

UCD School of Agriculture and Food Science, Belfield, Dublin 4, Ireland.

出版信息

Eur J Pharm Sci. 2021 Mar 1;158:105685. doi: 10.1016/j.ejps.2020.105685. Epub 2020 Dec 23.

DOI:10.1016/j.ejps.2020.105685
PMID:33359131
Abstract

SNAC and C are intestinal permeation enhancers (PEs) used in formulations of peptides for oral delivery in clinical trials. Our aims were to compare their: (i) mechanism of action in isolated rat intestinal mucosae mounted in Ussing chambers and in non-everted gut sacs, (ii) effects on mucosa integrity in those models and also in in situ intra-jejunal instillations and (iii) interactions with intestinal mucus. SNAC increased the apparent permeability coefficient (P) of the paracellular marker, FITC-dextran 4000 (FD4), across isolated rat gastric mucosae in concentration-dependent fashion, whereas C did not, while both reduced the transepithelial electrical resistance (TEER). In isolated jejunal and colonic mucosae, both agents increased the P of [C]-mannitol and FD4 whereas C but not SNAC reduced TEER. 20 mM SNAC was required to achieve the efficacy of 10 mM C in jejunal and colonic mucosae. In isolated non-everted jejunal and colonics sacs, FD4 flux increases were observed in the presence of both PEs. Histology of mucosae revealed that both PEs induced minor epithelial damage to the mucosa at concentrations that increased fluxes. Jejunal tissue withstood epithelial damage in the following order: intra jejunal in situ instillations > jejunal sacs > isolated jejunal mucosae. Both PEs modulated viscoelastic properties of porcine jejunal mucus without altering rheological properties. In conclusion, SNAC and C are reasonably efficacious PEs in rat intestinal tissue with common overall mechanistic features. Their potency and toxic potential are low, in agreement with clinical trial data.

摘要

SNAC和C是在临床试验中用于肽口服给药制剂的肠道渗透促进剂(PEs)。我们的目的是比较它们:(i)在安装于尤斯灌流室的离体大鼠肠黏膜和非外翻肠囊中作用机制,(ii)在这些模型以及原位空肠内灌注中对黏膜完整性的影响,以及(iii)与肠道黏液的相互作用。SNAC以浓度依赖方式增加了细胞旁标记物异硫氰酸荧光素葡聚糖4000(FD4)跨离体大鼠胃黏膜的表观渗透系数(P),而C则没有,同时两者都降低了跨上皮电阻(TEER)。在离体空肠和结肠黏膜中,两种药物都增加了[C]-甘露醇和FD4的P,而C降低了TEER,SNAC则没有。在空肠和结肠黏膜中,需要20 mM的SNAC才能达到10 mM C的效果。在离体非外翻空肠和结肠囊中,在两种PEs存在的情况下均观察到FD4通量增加。黏膜组织学显示,在增加通量的浓度下,两种PEs均对黏膜造成轻微上皮损伤。空肠组织对上皮损伤的耐受顺序为:原位空肠内灌注>空肠囊>离体空肠黏膜。两种PEs均调节了猪空肠黏液的粘弹性特性,而未改变其流变学特性。总之,SNAC和C在大鼠肠道组织中是相当有效的PEs,具有共同的总体作用机制特征。它们的效力和潜在毒性较低,与临床试验数据一致。

相似文献

1
Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C): Isolated rat intestinal mucosae and sacs.肠道渗透促进剂SNAC与癸酸钠(C)的效果比较:离体大鼠肠黏膜和肠囊
Eur J Pharm Sci. 2021 Mar 1;158:105685. doi: 10.1016/j.ejps.2020.105685. Epub 2020 Dec 23.
2
A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C).Caco-2 细胞模型中肠渗透促进剂:N-乙酰半胱氨酸和癸酸钠(C)作用机制的头对头比较。
Eur J Pharm Biopharm. 2020 Jul;152:95-107. doi: 10.1016/j.ejpb.2020.04.023. Epub 2020 May 6.
3
Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.水杨酸钠(SNAC)可增加奥曲肽在 Ussing chambers 中的离体大鼠和人肠道上皮黏膜中的通透性。
Eur J Pharm Sci. 2020 Nov 1;154:105509. doi: 10.1016/j.ejps.2020.105509. Epub 2020 Aug 8.
4
Labrafac MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies.Labrafac MC60 是一种有效的大分子肠道渗透增强剂:在离体和体内大鼠研究中与 Labrasol® ALF 的比较。
Int J Pharm. 2024 Aug 15;661:124353. doi: 10.1016/j.ijpharm.2024.124353. Epub 2024 Jun 22.
5
Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.米索前列醇可预防癸酸钠诱导的肠道通透性增加和上皮损伤。
Eur J Pharm Biopharm. 2015 Aug;94:194-206. doi: 10.1016/j.ejpb.2015.05.013. Epub 2015 May 27.
6
Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.两种促进剂的肠道吸收增强作用和局部黏膜毒性评价。I. 在分离的大鼠和人结肠黏膜中的研究。
Eur J Pharm Sci. 2009 Nov 5;38(4):291-300. doi: 10.1016/j.ejps.2009.09.001. Epub 2009 Sep 6.
7
Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.甘氨脱氧胆酸钠和脱氧胆酸钠作为上皮渗透促进剂:体外和离体肠道及口腔生物测定
Eur J Pharm Sci. 2021 Apr 1;159:105737. doi: 10.1016/j.ejps.2021.105737. Epub 2021 Jan 29.
8
Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.由中链脂肪酸衍生物10-十一碳烯酸钠诱导的有效肠道渗透增强作用。
AAPS J. 2014 Sep;16(5):1064-76. doi: 10.1208/s12248-014-9634-3. Epub 2014 Jun 25.
9
Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.评价烷基麦芽苷作为肠道渗透促进剂的效果:大鼠肠黏膜片与 Caco-2 单层细胞的比较。
Eur J Pharm Sci. 2012 Nov 20;47(4):701-12. doi: 10.1016/j.ejps.2012.08.010. Epub 2012 Aug 23.
10
Labrasol and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.低浓度的 Labrasol 和中链脂肪酸盐可以联合使用,增加大分子标记物穿过离体大鼠肠黏膜的通透性。
J Pharm Sci. 2018 Jun;107(6):1648-1655. doi: 10.1016/j.xphs.2018.02.012. Epub 2018 Feb 17.

引用本文的文献

1
Modification of Peptide and Permeation Enhancer In Vitro Release Rates by Dispersion with a Gel-Forming Polymer.通过与凝胶形成聚合物分散来改变肽和渗透促进剂的体外释放速率
Pharm Res. 2025 Jun 6. doi: 10.1007/s11095-025-03870-y.
2
Ion transport and epithelial barrier dysfunction in experimental models of ulcerative colitis.溃疡性结肠炎实验模型中的离子转运与上皮屏障功能障碍
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G811-G830. doi: 10.1152/ajpgi.00204.2024. Epub 2025 Apr 4.
3
Maternal milk cell components are uptaken by infant liver macrophages via extracellular vesicle mediated transport.
母乳中的细胞成分通过细胞外囊泡介导的转运被婴儿肝脏巨噬细胞摄取。
FASEB J. 2025 Jan 31;39(2):e70340. doi: 10.1096/fj.202402365R.
4
Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?超越癸酸钠和 SNAC 的胃肠道渗透增强剂 - 接下来会有什么?
Adv Sci (Weinh). 2024 Sep;11(33):e2400843. doi: 10.1002/advs.202400843. Epub 2024 Jun 17.
5
Neonatal intestinal mucus barrier changes in response to maturity, inflammation, and sodium decanoate supplementation.新生儿肠道黏液屏障对成熟度、炎症和癸酸钠补充的反应变化。
Sci Rep. 2024 Apr 1;14(1):7665. doi: 10.1038/s41598-024-58356-5.
6
Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery.突破壁垒:针对动态紧密连接的新型靶向方法以改善药物递送。
Adv Drug Deliv Rev. 2023 Aug;199:114905. doi: 10.1016/j.addr.2023.114905. Epub 2023 Jun 3.
7
Long-term daily oral administration of intestinal permeation enhancers is safe and effective in mice.长期每日口服肠道渗透促进剂对小鼠是安全有效的。
Bioeng Transl Med. 2022 May 31;8(1):e10342. doi: 10.1002/btm2.10342. eCollection 2023 Jan.
8
SNAC for Enhanced Oral Bioavailability: An Updated Review.SNAC 增强口服生物利用度:最新综述。
Pharm Res. 2023 Mar;40(3):633-650. doi: 10.1007/s11095-022-03459-9. Epub 2022 Dec 20.
9
In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.基于计算机的几种肠道渗透增强剂与脂质双层模型的相互作用机制的实验研究。
Mol Pharm. 2022 Jan 3;19(1):124-137. doi: 10.1021/acs.molpharmaceut.1c00689. Epub 2021 Dec 16.